Wikisage, the free encyclopedia of the second generation, is digital heritage
Dravet's syndrome: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
m (→Links) |
||
| Line 12: | Line 12: | ||
[[Epidiolex|CBD]] | [[Epidiolex|CBD]] | ||
Dravet, Charlotte & Hirokazu Oguni [https://linkinghub.elsevier.com/retrieve/pii/B978-0-444-52891-9.00065-8 DRAVET syndrome (severe myoclonic epilepsy in infancy) | [[charlotte Dravet|Dravet, Charlotte]] & Hirokazu Oguni [https://linkinghub.elsevier.com/retrieve/pii/B978-0-444-52891-9.00065-8 DRAVET syndrome (severe myoclonic epilepsy in infancy) | ||
[http://scielo.isciii.es/pdf/albacete/v7n2/paciente2.pdf síndrome de Dravet] | [http://scielo.isciii.es/pdf/albacete/v7n2/paciente2.pdf síndrome de Dravet] | ||
Revision as of 20:47, 26 February 2019
Generalized epilepsy with febrile seizures plus Dravet syndrome corresponds a phenotype severe myoclonic epilepsy of infancy (SMEI), a form of intractable epilepsy of childhood.[1] [2] Prompt and precise diagnosis of Dravet is critical, due to the high risk of status epilepticus and sudden unexplained death in epilepsy (SUDEP), and that commonly prescribed antiepileptic sodium channel blockers aggravate Dravet seizures [3]
Links
Dravet, Charlotte & Hirokazu Oguni [https://linkinghub.elsevier.com/retrieve/pii/B978-0-444-52891-9.00065-8 DRAVET syndrome (severe myoclonic epilepsy in infancy)
Rev Clin Med fam 7(2): 134-136
Disease classification WHO
G40.3 Dravet's syndrome